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dose-length product (DLP). Although the DLP is related to
patient dose and risk, it is unique to CT and is not useful
for comparisons with other modalities. The International
Commission on Radiation Projection (ICRP) uses the
concept of effective dose (E), in units of J/kg or sievert
(Sv), to quantify risk [1,2]. The E is a weighted sum of the
organ doses, in which the weights represent the relative
sensitivity of organs to radiation damage and their contri-
bution to overall determinant from stochastic effects
(cancer). Generally, the risk of a fatal cancer for adults is
estimated at 5%/Sv [1] and is higher for children. DLP-to-E
conversion factors have been derived and are useful in
quickly estimating patient risk from the DLP values re-
ported by CT systems [3,4]. Recently, the ICRP updated the
tissue-weighting factors [1], which necessitates that the
DLP-to-E conversion factors be updated as well. Several
articles have proposed new DLP-to-E conversion factors for
the case of a single CT scanner model [5,6]. Recently,
Huda et al [7] published updated average conversion factors
based on ICRP 103 but did not provide scanner-specific
results.
In this technical note, we present DLP-to-E conversion
factors for 7 common CT examinations (brain, sinuses,
lumbar spine, chest, abdomen-pelvis, cardiac angiography,
and chest-abdomen-pelvis) and for 7 scanner models in use
in Manitoba and other parts of Canada. We also present* Address for correspondence: Idris Elbakri, PhD, Division of Medical
Physics, CancerCare Manitoba, 675 McDermot Ave, Winnipeg, Manitoba
R3E 0V9, Canada.
E-mail address: Idris.Elbakri@cancercare.mb.ca (I. A. Elbakri).
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doi:10.1016/j.carj.2011.12.013average conversion factors that can be applied, irrespective
of scanner model. This work was carried out to facilitateFigure 1. ImPACT (Imaging Performance Assessment of Computed
Tomography Scanners) CT Patient Dosimetry Calculator numerical
phantom, showing the scan range for the brain, starting at 80 cm and ending
at 93 cm. This figure is available in colour online at http://carjonline.org/.
ll rights reserved.
Table 1
Scan start and end locations used in the ImPACT CT calculator for the
clinical examinations considered in this study (start-end cm)
Brain Sinuses LSP Chest ABD/P Angio CAP
80-93 80-89.5 4-39.5 43-70.5 0.5-44.5 43.5-57.5 0.5-70.5
ABD/P ¼ abdomen-pelvis CT; Angio ¼ cardiac angiography; CAP ¼ chest
abdomen-pelvis CT; CT ¼ computed tomography; ImPACT ¼ Imaging
Performance Assessment of Computed Tomography Scanners; LSP ¼
lumbar spine CT.
Table 2
Scanner models in use in Manitoba for which DLP-to-E conversion factors
were determined
Scanner model
No. detector
rows
Maximum beam
width (mm)
GE LightSpeed VCTa 64 40
GE LightSpeed 16a 16 20
Siemens Definition ASb 64 19.2
GE HiSpeed Nx/I Proa 2 20
GE HiSpeed Qx/ia 4 20
Toshiba Aquilionc 16 32
Toshiba Asteionc 4 32
DLP ¼ dose-length product; E ¼ effective dose.
a
16 I. A. Elbakri, I. D. C. Kirkpatrick / Canadian Association of Radiologists Journal 64 (2013) 15e17calculating E from data obtained as a part of a provincial
dose survey that has not yet been published.From GE Healthcare, Waukesha, WI.
b From Siemens Healthcare, Forchheim, Germany.
c FromToshiba Medical Systems, Otawara, Japan.Materials and Methods
We determined DLP-to-E conversion factors for adult
patients by using the ImPACT (Imaging Performance
Assessment of Computed Tomography Scanners) CT Patient
Dosimetry Calculator (version 1.0.2) [8]. The ImPACT CT
Patient Dosimetry Calculator is implemented as an Excel
spreadsheet (Microsoft Corp., Redmon, WA) and is based on
Monte Carlo dose data described in the National Radiolog-
ical Protection Board’s report SR250 [9]. The user inputs the
CT scanning parameter and the start and end locations of the
CT scan, and the ImPACT spreadsheet calculates the CT
dose index (CTDI), DLP, and E for a standard hermaphrodite
phantom.
The second author (I.D.C.K.) identified the start and end
locations of each examination on the ImPACT spreadsheet
patient figure, based on direct clinical experience with CT
images from all CT scanners in Manitoba. The start and end
locations of brain scans on the ImPACT spreadsheet patient
figure are illustrated in Figure 1. The start and end points for
all the examinations considered are listed in Table 1.
The scanner models included in this study are listed in
Table 2. In the ImPACT dose spreadsheet, we set the kVp toTable 3
DLP-to-E conversion factors (mSv/mGy$cm) for all scanners and clinical protoc
Brain Sinuses LSP
GE LightSpeed VCTa 2.8 3.1 17.
GE LightSpeed 16a 2.6 2.8 19.
Siemens Definition ASb 2.7 3.0 20.
GE HiSpeed Nx/I Proa 2.6 2.8 22.
GE HiSpeed Qx/ia 2.6 2.8 20.
Toshiba Aquilionc 2.3 2.5 20.
Toshiba Asteionc 2.6 2.8 17.
Average (SD) 2.6  0.15 2.8  0.19 19.
Maximum deviation from the average, % 11 11 15
European factors (ICRP 60)d 2.3
Factors of Huda et al (ICRP 103)e 2.4
ABD/P ¼ abdomen-pelvis computed tomography; Angio ¼ cardiac angiography
product; E ¼ effective dose; ICRP ¼ International Commission on Radiological
a From GE Healthcare, Waukesha, WI.
b From Siemens Healthcare, Forchheim, Germany.
c From Toshiba Medical Systems, Otawara, Japan.
d From Ref. 4.
e From Ref. 5.120 and the collimation field to the maximum beam width
available. We used a pitch value of 1, a tube current of
100 mA, and a scan time of 1 second. We assumed a CTDI
phantom 16 cm in diameter for the head region and a CTDI
phantom 32 cm in diameter for all other regions. The
ImPACT spreadsheet computed the E and the DLP, from
which their conversion factor could be determined. We
calculated DLP-to-E conversion factors for each scanner
model and averaged them over all scanner models. We also
determined their standard deviations and the maximum
deviation from the mean.
Results and Discussion
The results for all scanners and their averages are
summarized in Table 3. To facilitate comparisons, we also
list the conversion factors used in the European CT quality-
control standards [4] (based on ICRP 60) and those recently
reported by Huda et al [7] (based on ICRP 103). Maximum
deviation between scanner-specific conversion factors, and
their averages were in the range of 10%-15%. Except for theols considered in this study
Chest ABD/P Angio CAP
4 16.7 16.5 27.1 18.0
5 19.0 16.1 26.6 17.3
3 20.1 16.1 28.0 17.6
8 21.8 18.1 30.0 19.5
0 19.4 16.1 27.0 17.3
5 19.8 16.7 27.5 17.9
9 19.2 14.3 27.6 16.6
8  1.78 19.4  1.51 16.3  1.14 27.6  1.01 17.8  0.89
14 12 7 10
17.0 15.0-19.0
20.4 17.1 18.6
; CAP ¼ chest-abdomen-pelvis computed tomography; DLP ¼ dose-length
Protection; LSP ¼ lumbar spine computed tomography.
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computed are higher than those based on ICRP 60.
The user has the choice between the scanner-specific
conversion factor or can use average conversion factors.
This range of variation of scanner-specific factors relative to
their averages is larger than that reported by others [3]. Our
study spans several models of scanners with detector rows
that range from 2-64. The study described in the European
guidelines on quality criteria for computed tomography [4],
for example, reports on variations among 4 models of 16-
slice scanners. Given the uncertainties inherent in the
calculation of E [10], using average conversion factors is
quite defensible.
The conversion factors proposed in this note are based on
a single-tube potential of 120 kVp. Results of previous work
indicate that conversion factors do not vary significantly
with energy [5,6]. In addition, the choice of 120 kVp is
ubiquitous in clinical practice in Manitoba. The ImPACT
Dosimetry Calculator does not take into account automatic
tube current modulation. With tube current modulation in
place, it is estimated that E determined from DLP-to-E
conversion factors is overestimated by 8%-11% [3,11]. The
conversion factors provide clinicians and physicists with
a quick and relatively accurate method to estimate E and
patient risk. The E should be used with care. It does not
represent the risk to any particular patient but is a useful
concept for dose optimization, comparing technologies and
modalities, and for population-based dose surveys and risk
assessments [10].References
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